RR

Rasetty Rajesh

Active Director Director DIN 10871787
DIN 10871787 First appointment Dec 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value •••• Premium profile

About Rasetty Rajesh

Data last updated:

Rasetty Rajesh is a Director at Lotus Hospitals India Limited (since 2024). The company operates in Healthcare. Lotus Hospitals India Limited reported revenue of ₹9.03 Cr (FY 2025).

DIN 10871787
Primary Designation Director
Industry Healthcare
First Appointment 14 Dec 2024
Oldest Company Age 4 yrs
Largest company Lotus Hospitals India Limited · ₹9.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lotus Hospitals India Limited U85300TN2022PLC152448
Director14 Dec 20242022₹9.03 Cr (FY 2025)Active

Board colleagues of Rasetty Rajesh

Directorship timeline

Open interactive timeline →
Lotus Hospitals India Limited
Premium access

Shareholding and investment profile for Rasetty Rajesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rasetty Rajesh

Rasetty Rajesh currently holds 1 directorship: Lotus Hospitals India Limited (Director, since 14 Dec 2024, revenue ₹9.03 Cr (FY 2025)).

Rasetty Rajesh was first appointed on 14 Dec 2024 as Director at Lotus Hospitals India Limited.

The current boards of Rasetty Rajesh's companies include Chilukoti Parameswari (Lotus Hospitals India Limited), Somala Satish Babu (Lotus Hospitals India Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available